An article published in the journal Brain Communications, coordinated by Carlos Barcia, researcher at INc-UAB, describes how the immune system facilitates the expansion of tumour cells in the brain. The study was performed on human samples of glioblastoma, the most aggressive brain tumour, and on cell culture models.
The publication, co-ordinated by ICTA-UAB researcher Feredico Demaria with other international experts, presents a large inventory of alternative practices to "development" as a predominant way of life in today's society.
The new low-cost, environmentally friendly and scalable method, designed by ICMAB-CSIC researchers in collaboration with the UAB, represents a breakthrough in the production of superconducting materials.
The UAB will coordinate the European project ITFLOWS on prediction and management of migratory flows
This European project, coordinated by the Institute of European Studies of the UAB, seeks to contribute in generating novel insights on migration. The purpose of ITFLOWS is to provide accurate predictions and adequate management solutions of migration flows in the European Union.
Discovery of an adaptation process key to the survival of Mycoplasma genitalium in the urogenital tract
A study led by an IBB-UAB research team has managed to identify the mechanisms by which the sexually transmitted bacterium Mycoplasma genitalium (Mge) can persist in conditions with very limited availability of metals, a circumstance it must face when infecting humans. The discovery will facilitate the development of therapeutic strategies to fight against this pathogen, which is becoming resistant to antibiotics.
A new research by the UAB, the Hospital Sant Pau and the CIBER-BBN has developed a new biomaterial with sustained drug release. The results were recently published in Advanced Science and describe the creation of artificial inclusion bodies for uses in precision biotechnology and nanomedicine.
This article reflects on what use is given to drugs and considers what strategies could be used to avoid their serious adverse reactions. Read more